Sexually dimorphic effects of monoacylglycerol lipase inhibitor MJN110 on stress‐related behaviour and drinking in Marchigian Sardinian alcohol‐preferring rats

Abstract

AbstractBackground and PurposeThe endocannabinoid (eCB) system plays an important homeostatic role in the regulation of stress circuits and has emerged as a therapeutic target to treat stress disorders and alcohol use disorder (AUD). Extensive research has elucidated a role for the eCB anandamide (AEA), but less is known about 2‐arachidonoylglycerol (2‐AG) mediated signalling.Experimental ApproachWe pharmacologically enhanced eCB signalling by inhibiting the 2‐AG metabolizing enzyme, monoacylglycerol lipase (MAGL), in male and female Marchigian Sardinian alcohol‐preferring (msP) rats, a model of innate alcohol preference and stress hypersensitivity, and in control Wistar rats. We tested the acute effect of the selective MAGL inhibitor MJN110 in alleviating symptoms of alcohol drinking, anxiety, irritability and fear.Key ResultsA single systemic administration of MJN110 increased 2‐AG levels in the central amygdala, prelimbic and infralimbic cortex but did not acutely alter alcohol drinking. MAGL inhibition reduced aggressive behaviours in female msPs, and increased defensive behaviours in male msPs, during the irritability test. Moreover, in the novelty‐induced hypophagia test, MJN110 selectively enhanced palatable food consumption in females, mitigating stress‐induced food suppression. Lastly, msP rats showed increased conditioned fear behaviour compared with Wistar rats, and MJN110 reduced context‐associated conditioned fear responses, but not cue‐probed fear expression, in male msPs.Conclusions and ImplicationsAcute inhibition of MAGL attenuated some stress‐related responses in msP rats but not voluntary alcohol drinking. Our results provide new insights into the sex dimorphism documented in stress‐induced responses. Sex‐specific eCB‐based approaches should be considered in the clinical development of therapeutics.